MYRIAD GENETICS INC

MYGN · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $0.4B · 2,700 employees
192
SEC Filings
$4.31
Close 2026-06-02
2,700
Employees

Business Summary

PART I Overview and Mission Myriad Genetics is a leading molecular diagnostics and precision medicine company committed to advancing health and well-being for all. We develop and commercialize molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more ...

Latest Stock Quote

MYGN 2026-06-02 $4.31 O:$4.22 H:$4.445 L:$4.115 Vol:2.4M VWAP:$4.3141
origin leaf: 5527c06669069dcf19a70c647474d349fc8a09a1ed15822b0fa86a579fc95e2f

Next Earnings

Q2 FY2026 — expected 2026-08-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310000899923-26-000018EDGAR72K words
2025-02-282024-12-310000899923-25-000019EDGAR—
2024-02-282023-12-310000899923-24-000018EDGAR—
2023-03-012022-12-310000899923-23-000011EDGAR—
2022-02-252021-12-310000899923-22-000033EDGAR—
2020-08-132020-06-300001564590-20-040011EDGAR—
2019-08-132019-06-300001564590-19-031849EDGAR—
2018-08-242018-06-300001564590-18-022312EDGAR—
2017-08-092017-06-300001564590-17-017026EDGAR—
2016-08-102016-06-300001193125-16-677859EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300000899923-25-000112EDGAR20K words
2025-08-062025-06-300000899923-25-000086EDGAR—
2025-05-072025-03-310000899923-25-000048EDGAR—
2024-11-082024-09-300000899923-24-000057EDGAR—
2024-08-072024-06-300000899923-24-000041EDGAR—
2024-05-082024-03-310000899923-24-000026EDGAR—
2023-11-072023-09-300000899923-23-000087EDGAR—
2023-08-042023-06-300000899923-23-000058EDGAR—
2023-05-042023-03-310000899923-23-000035EDGAR—
2022-11-022022-09-300000899923-22-000140EDGAR—
2022-08-052022-06-300000899923-22-000130EDGAR—
2022-05-062022-03-310000899923-22-000079EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230000899923-26-000012EDGAR9K words
2026-01-120000899923-26-000003EDGAR—
2025-11-030000899923-25-000103EDGAR—
2025-10-070000899923-25-000096EDGAR—
2025-10-030000899923-25-000091EDGAR—
2025-08-180000899923-25-000089EDGAR—
2025-08-050000899923-25-000084EDGAR—
2025-07-310000899923-25-000072EDGAR—
2025-06-050000899923-25-000066EDGAR—
2025-05-060000899923-25-000045EDGAR—

192 total filings indexed. 160 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0000899923
TickerMYGN
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE
Websitehttps://www.myriad.com
Listed1995-10-06

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8a499fac287ba10eec940ae38b267557ad5d1260b3b0721e9975faa8445b9cd7
parent: 2f50080b92a08d10156750f89c20fa4836d50fa426a581e398411cb9bccf64ff
content hash: 8ec0087f158ee99768997febbfe45adcf7c9248c0b60f998d75264d391840463
signed: 2026-06-03T12:01:56.734Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf